Johnson & Johnson (TSX:JNJ)
Canada · Delayed Price · Currency is CAD 33.97
+0.33 (0.98%)
Oct 26, 2026, 3:55 PM EDT
Johnson & Johnson Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 99,335 | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 |
Revenue Growth | 7.80% | 6.05% | 4.30% | 6.46% | 1.59% | -4.66% |
Gross Profit Gross Profit Growth | 67,324 | 64,128 | 61,785 | 58,915 | 55,394 | 55,338 |
Operating Income Operating Income Growth | 26,411 | 26,333 | 22,601 | 23,664 | 22,181 | 21,555 |
Net Income Net Income Growth | 16,095 | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 |
Earnings Per Share EPS Growth | 6.58 | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 |
EPS Growth | -36.37% | 90.50% | -57.81% | 103.94% | -13.84% | 41.75% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Innovative Medicine Innovative Medicine Growth | 64,330 | 60,401 | 56,964 | 54,759 | 52,563 | 51,680 |
MedTech MedTech Growth | 35,005 | 33,792 | 31,857 | 30,400 | 27,427 | 27,060 |
Revenue (Total) Revenue (Total) Growth | - | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 17,228 | 20,102 | 24,522 | 22,927 | 22,281 | 31,608 |
Total Debt Total Debt Growth | 44,651 | 49,333 | 37,834 | 30,432 | 40,742 | 34,751 |
Net Cash (Debt) Net Cash Growth | -27,423 | -29,231 | -13,312 | -7,505 | -18,461 | -3,143 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.22 | -12.03 | -5.48 | -2.93 | -6.93 | -1.18 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 26,159 | 24,530 | 24,266 | 22,791 | 21,194 | 23,410 |
Capital Expenditures CapEx Growth | -5,569 | -4,832 | -4,424 | -4,381 | -3,706 | -3,652 |
Free Cash Flow Free Cash Flow Growth | 20,590 | 19,698 | 19,842 | 18,410 | 17,488 | 19,758 |
Free Cash Flow Growth | 5.07% | -0.73% | 7.78% | 5.27% | -11.49% | -2.14% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 67.77% | 68.08% | 69.56% | 69.18% | 69.25% | 70.28% |
Operating Margin | 26.59% | 27.96% | 25.45% | 27.79% | 27.73% | 27.38% |
Pretax Margin | 17.86% | 34.59% | 18.79% | 17.69% | 24.20% | 24.36% |
Profit Margin | 16.20% | 28.46% | 15.84% | 41.28% | 22.43% | 26.52% |
FCF Margin | 20.73% | 20.91% | 22.34% | 21.62% | 21.86% | 25.09% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.679 | 5.140 | 4.910 | 4.700 | 4.450 | 4.190 |
Dividend Per Share Growth | 1.58% | 4.68% | 4.47% | 5.62% | 6.21% | 5.28% |
Dividend Yield | 2.00% | 2.47% | 3.38% | 3.00% | 2.52% | 2.45% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | 55.20 | 18.66 | 24.83 | 10.73 | 25.74 | 21.57 |
P/FCF Ratio | 30.87 | 25.40 | 17.60 | 20.50 | 26.41 | 22.79 |
PS Ratio | 6.40 | 5.31 | 3.93 | 4.43 | 5.77 | 5.72 |